Study Provides Real-World Evidence for Inflammatory DED - Summary - MDSpire

Study Provides Real-World Evidence for Inflammatory DED

  • By

  • Julie Greenbaum, editor

  • Julie Greenbaum, editor

  • April 11, 2026

  • 4 min

Share

Objective:

To evaluate the characteristics, treatment, and diagnostic practices for patients with dry eye disease (DED) using real-world data, focusing on those diagnosed on or after January 1, 2016.

Approach:
    Key Findings:
    • Predominantly female population (80%) with a mean age of 61 years.
    • Cataract was the most common ocular comorbidity; hyperlipidemia (45%) and hypertension (43%) were the most common nonocular comorbidities.
    • Only 10% of patients had used other therapies prior to lifitegrast, indicating a large untreated population.
    • Dry eye diagnostic testing was underutilized; only 3.9% had an abnormal tear breakup time.
    • Racial distribution included approximately 55% White, 5% Black, 5% Asian, 9% other, and 25% unknown.
    Interpretation:

    The study reveals significant comorbidities in DED patients and highlights the underutilization of diagnostic testing, indicating a need for improved management strategies to address these gaps.

    Limitations:
    • The study may not fully represent all demographics due to the predominance of certain racial and ethnic groups, potentially affecting the generalizability of the findings.
    • Data on diagnostic tests was incomplete, with a high percentage of unknown results.
    Conclusion:

    This real-world study underscores the need for better diagnostic practices and treatment strategies for DED patients.

Original Source(s)

Related Content